Lakeshore Biopharma Co, Stock Probability of Future Stock Price Finishing Under 2.64
| LSB Stock | 2.75 0.23 7.72% |
LakeShore |
LakeShore Biopharma Target Price Odds to finish below 2.64
The tendency of LakeShore Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to drop to 2.64 or more in 90 days |
| 2.75 | 90 days | 2.64 | about 20.06 |
Based on a normal probability distribution, the odds of LakeShore Biopharma to drop to 2.64 or more in 90 days from now is about 20.06 (This LakeShore Biopharma Co, probability density function shows the probability of LakeShore Stock to fall within a particular range of prices over 90 days) . Probability of LakeShore Biopharma Co, price to stay between 2.64 and its current price of 2.75 at the end of the 90-day period is about 1.66 .
Considering the 90-day investment horizon LakeShore Biopharma has a beta of 0.68. This indicates as returns on the market go up, LakeShore Biopharma average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding LakeShore Biopharma Co, will be expected to be much smaller as well. Additionally LakeShore Biopharma Co, has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. LakeShore Biopharma Price Density |
| Price |
Predictive Modules for LakeShore Biopharma
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as LakeShore Biopharma Co,. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of LakeShore Biopharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
LakeShore Biopharma Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. LakeShore Biopharma is not an exception. The market had few large corrections towards the LakeShore Biopharma's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold LakeShore Biopharma Co,, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of LakeShore Biopharma within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.21 | |
β | Beta against Dow Jones | 0.68 | |
σ | Overall volatility | 1.91 | |
Ir | Information ratio | -0.02 |
LakeShore Biopharma Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of LakeShore Biopharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for LakeShore Biopharma Co, can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| LakeShore Biopharma generated a negative expected return over the last 90 days | |
| LakeShore Biopharma has high historical volatility and very poor performance | |
| LakeShore Biopharma has a very high chance of going through financial distress in the upcoming years | |
| LakeShore Biopharma Co, was previously known as YS Biopharma Co, and was traded on NASDAQ Exchange under the symbol YS. | |
| The company reported the last year's revenue of 573.42 M. Reported Net Loss for the year was (433.46 M) with profit before taxes, overhead, and interest of 0. | |
| LakeShore Biopharma generates negative cash flow from operations | |
| LakeShore Biopharma has a frail financial position based on the latest SEC disclosures | |
| About 81.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from finance.yahoo.com: LakeShore Biopharma Initiates Biologics License Application of PIKA Rabies Vaccine to the Drug Regulatory Authority of Pakistan |
LakeShore Biopharma Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of LakeShore Stock often depends not only on the future outlook of the current and potential LakeShore Biopharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. LakeShore Biopharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 106.9 M | |
| Cash And Short Term Investments | 246.4 M |
LakeShore Biopharma Technical Analysis
LakeShore Biopharma's future price can be derived by breaking down and analyzing its technical indicators over time. LakeShore Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of LakeShore Biopharma Co,. In general, you should focus on analyzing LakeShore Stock price patterns and their correlations with different microeconomic environments and drivers.
LakeShore Biopharma Predictive Forecast Models
LakeShore Biopharma's time-series forecasting models is one of many LakeShore Biopharma's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary LakeShore Biopharma's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about LakeShore Biopharma Co,
Checking the ongoing alerts about LakeShore Biopharma for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for LakeShore Biopharma Co, help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| LakeShore Biopharma generated a negative expected return over the last 90 days | |
| LakeShore Biopharma has high historical volatility and very poor performance | |
| LakeShore Biopharma has a very high chance of going through financial distress in the upcoming years | |
| LakeShore Biopharma Co, was previously known as YS Biopharma Co, and was traded on NASDAQ Exchange under the symbol YS. | |
| The company reported the last year's revenue of 573.42 M. Reported Net Loss for the year was (433.46 M) with profit before taxes, overhead, and interest of 0. | |
| LakeShore Biopharma generates negative cash flow from operations | |
| LakeShore Biopharma has a frail financial position based on the latest SEC disclosures | |
| About 81.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from finance.yahoo.com: LakeShore Biopharma Initiates Biologics License Application of PIKA Rabies Vaccine to the Drug Regulatory Authority of Pakistan |
Check out LakeShore Biopharma Backtesting, LakeShore Biopharma Valuation, LakeShore Biopharma Correlation, LakeShore Biopharma Hype Analysis, LakeShore Biopharma Volatility, LakeShore Biopharma History as well as LakeShore Biopharma Performance. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of LakeShore Biopharma. If investors know LakeShore will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about LakeShore Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.57) | Revenue Per Share 5.363 | Quarterly Revenue Growth 0.277 | Return On Assets (0.14) | Return On Equity (0.66) |
The market value of LakeShore Biopharma Co, is measured differently than its book value, which is the value of LakeShore that is recorded on the company's balance sheet. Investors also form their own opinion of LakeShore Biopharma's value that differs from its market value or its book value, called intrinsic value, which is LakeShore Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because LakeShore Biopharma's market value can be influenced by many factors that don't directly affect LakeShore Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between LakeShore Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if LakeShore Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, LakeShore Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.